Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ty M Thomson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMC Research Notes|August 13, 2014
An algorithm for score aggregation over causal biological networks based on random walk samplingDmitry M Vasilyev, Ty M Thomson, Brian P Frushour, et al.
BMC Systems Biology|June 2, 2012
Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networksFlorian Martin, Ty M Thomson, Alain Sewer, et al.
BMC Medical Genomics|June 4, 2015
Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritisTy M Thomson, Reynald M Lescarbeau, David A Drubin, et al.
Drug Discovery Today|December 14, 2011
A network-based approach to quantifying the impact of biologically active substancesJulia Hoeng, Renée Deehan, Dexter Pratt, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2011
Scaffold number in yeast signaling system sets tradeoff between system output and dynamic rangeTy M Thomson, Kirsten R Benjamin, Alan Bush, et al.
Nature Communications|November 2, 2023
Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptidesOlena S Tokareva, Kunhua Li, Tara L Travaline, et al.
Toxicology and Applied Pharmacology|August 13, 2013
Quantitative assessment of biological impact using transcriptomic data and mechanistic network modelsTy M Thomson, Alain Sewer, Florian Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2022
De novo mapping of α-helix recognition sites on protein surfaces using unbiased librariesKunhua Li, Olena S Tokareva, Ty M Thomson, et al.
Molecular Cancer Therapeutics|April 22, 2017
Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in <i>MLL</i>-Rearranged LeukemiaCarly T Campbell, Jessica N Haladyna, David A Drubin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMC Research Notes|August 13, 2014
An algorithm for score aggregation over causal biological networks based on random walk samplingDmitry M Vasilyev, Ty M Thomson, Brian P Frushour, et al.
BMC Systems Biology|June 2, 2012
Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networksFlorian Martin, Ty M Thomson, Alain Sewer, et al.
BMC Medical Genomics|June 4, 2015
Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritisTy M Thomson, Reynald M Lescarbeau, David A Drubin, et al.
Drug Discovery Today|December 14, 2011
A network-based approach to quantifying the impact of biologically active substancesJulia Hoeng, Renée Deehan, Dexter Pratt, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2011
Scaffold number in yeast signaling system sets tradeoff between system output and dynamic rangeTy M Thomson, Kirsten R Benjamin, Alan Bush, et al.
Nature Communications|November 2, 2023
Recognition and reprogramming of E3 ubiquitin ligase surfaces by α-helical peptidesOlena S Tokareva, Kunhua Li, Tara L Travaline, et al.
Toxicology and Applied Pharmacology|August 13, 2013
Quantitative assessment of biological impact using transcriptomic data and mechanistic network modelsTy M Thomson, Alain Sewer, Florian Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2022
De novo mapping of α-helix recognition sites on protein surfaces using unbiased librariesKunhua Li, Olena S Tokareva, Ty M Thomson, et al.
Molecular Cancer Therapeutics|April 22, 2017
Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in <i>MLL</i>-Rearranged LeukemiaCarly T Campbell, Jessica N Haladyna, David A Drubin, et al.
Pageof 1